• Keine Ergebnisse gefunden

Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to “A survey on the current status of clinical resources for diagnosis and treatment of breast cancer

N/A
N/A
Protected

Academic year: 2022

Aktie "Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to “A survey on the current status of clinical resources for diagnosis and treatment of breast cancer "

Copied!
2
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Vol.:(0123456789)

1 3

Breast Cancer (2021) 28:1163–1164 https://doi.org/10.1007/s12282-021-01254-9

LETTER TO THE EDITOR

Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to “A survey on the current status of clinical resources for diagnosis and treatment of breast cancer

in rural hospitals of the Tohoku region in Japan”

Akihiko Ozaki1  · Kazunoshin Tachibana2 · Tohru Ohtake2

Received: 30 March 2021 / Accepted: 15 April 2021 / Published online: 20 April 2021

© The Japanese Breast Cancer Society 2021

Keywords Breast cancer · Fukushima nuclear accident · COVID-19 · Rural health

Ishikawa et al. investigated the current status of breast cancer care in rural hospitals in Tohoku and reported that breast cancer surgeons of these hospitals who responded to the survey emphasized the importance of treating patients in their own hospitals rather than referring them to larger urban hospitals [1]. However, we are concerned that the authors do not cover all potential problems faced by rural hospitals in Tohoku currently. The lead author of this correspondence also responded to the survey.

First, the authors did not discuss the impact of the 2011 triple disaster (earthquake, tsunami, and the Fukushima Dai- ichi Nuclear Power Plant [FDNPP] accident) on the region.

Iwate, Miyagi, and Fukushima prefectures were severely affected, and Fukushima—which houses FDNPP in its coastal area—experienced particularly devastating and long- term damage. Concretely, the proportion of symptomatic breast cancer patients who delayed their first medical consul- tations increased in Minamisoma City—located 10–40 km to the north of FDNPP—after the disaster, and such changes continued for 5 years after the disaster [2]. This could be potentially explained by lowered prioritization of one’s own health due to post-disaster confusion and reduced support from families and friends owing to mass evacuation [2, 3].

Contrastingly, the time to treatment inception in the city was comparable before and after the disaster; additionally, the post-disaster patients were able to continue receiving post-treatment surveillance [3, 4], thus indicating the impor- tance of local facilities and physicians providing comprehen- sive breast cancer care in patients’ residential areas. Some survivors in Fukushima were evacuated to other prefectures in Tohoku and may have been cared for in rural hospitals.

Therefore, breast cancer surgeons in areas outside Fukush- ima ended up having similar awareness levels; this may have contributed to the present survey findings.

Second, the authors did not provide the clinical impli- cation of survey findings in the context of the global pan- demic of coronavirus disease (COVID-19). However, the role of rural hospitals cannot be emphasized enough given the COVID-19 pandemic, which has affected many health- care delivery aspects. Since the outbreak intensified in Japan in early 2020, it became challenging for rural hospitals in Tohoku to refer new breast cancer patients to urban hospi- tals owing to concerns regarding COVID-19 transmission such as contracting or transmitting the infection. Further, some rural patients who had regularly visited urban hospitals opted to receive care at rural hospitals during the pandemic, underlining the increased collaboration between urban and rural hospitals. This emphasizes the importance of preparing for organized breast cancer care in each area.

Breast cancer facilities in Fukushima have already imple- mented some novel approaches to mitigate these issues.

Specifically, Fukushima Medical University has taken the

* Akihiko Ozaki

ozakiakihiko@gmail.com

1 Department of Breast Surgery, Jyoban Hospital of Tokiwa Foundation, 57 Kaminodai, Jyoban-Kamiyunaga-Yamachi, Iwaki, Fukushima 972-8322, Japan

2 Department of Breast Surgery, Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan

(2)

1164 Breast Cancer (2021) 28:1163–1164

1 3

initiative to conduct a remote Breast Cancer Board Meetings monthly, ensuring a system that allows easy consultation for difficult cases at rural hospitals. While these initiatives are particularly important in Tohoku because of its large area, we believe that they have important implications in other regions as well, given the difficulties faced in Japan in con- trolling the COVID-19 pandemic.

Acknowledgements We appreciate the variable comments from Pro- fessor Shigehira Saji on this manuscript.

Declarations

Conflict of interest Dr. Ozaki receives personal fees from Medical Network Systems outside the scope of the submitted work. The other authors declare no conflicts of interest.

Research involving human participants and/or animals We did not obtain ethical clearance from institutional review boards since we judged that ethical review is not applicable to this work.

Informed consent Not applicable to this work.

References

1. Ishida K, Ohnuki K, Usami S, Komatsu H, Sasaki A. A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan.

Breast Cancer. 2021;28:161–7.

2. Ozaki A, Nomura S, Leppold C, Tsubokura M, Tanimoto T, Yokota T, et al. Breast cancer patient delay in Fukushima, Japan following the 2011 triple disaster: a long-term retrospective study.

BMC Cancer. 2017;17:423.

3. Ozaki A, Leppold C, Tsubokura M, Tanimoto T, Saji S, Kato S, et al. Social isolation and cancer management after the 2011 triple disaster in Fukushima, Japan: a case report of breast cancer with patient and provider delay. Medicine (Baltimore). 2016;95:e4027.

4. Ozaki A, Nomura S, Leppold C, Tsubokura M, Sawano T, Tsu- kada M, et al. Breast cancer provider interval length in Fukush- ima, Japan, after the 2011 triple disaster: a long-term retrospective study. Clin Breast Cancer. 2020;20:e127–50.

Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Referenzen

ÄHNLICHE DOKUMENTE

Supplementary Table 4: Odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between breast cancer risk factors and levels of the Nottingham prognostic index

Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.. Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner

(ii) the PROGNOSTIC collection ( N ¼ 826), including node negative patients with early breast cancers not treated with any systemic therapy until relapse; (iii) the TAM

Neoadjuvant che- motherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2- positive locally advanced breast cancer

Although she published no autobiographical accounts of her cancer experience, Leibovitz’s photo- graphic narrative and Rieff ’s “son’s memoir” have provoked controversy

Accordingly, inhibiting autophagy via silencing MAP1LC3 or BECN1 reduced the expression of cyclin D1, integrin-β1, and phosphorylated proto-oncogene tyrosine-protein kinase (SRC),

Kaplan-Meier plots for disease-free survival according to the timing of definitive surgery within the menstrual cycle (follicular or luteal phase) for premenopausal patients

We further demonstrate that knockdown of SHP2 in different breast cancer cell lines blocks tumor growth in vivo.. Mechanistically, SHP2 promoted ERK1/2 activation